June 7 - 12, 2008
Macao SAR, China
Venetian Macao Resort Hotel

Programme

Wednesday, June 11

PARALLEL SESSIONS

08.30 – 10.00 Ballroom G - L

Parallel Session S21: Challenges for the future in transfusion medicine
 

08.30 – 08.55
4A-S21-01 CLINICAL ASPECTS
P. Holland (Univ. of California,Davis Medical Center, Sacramento, USA)

08.55 – 09.20
4A-S21-02 AGING AND TRANSFUSION
W.G. van Aken (Amstelveen, The Netherlands)

09.20 – 09.45
4A-S21-03 GENOME WIDE ASSOCIATION MEETS SYSTEMS BIOLOGY DISCOVERING GENES IMPLICATED IN THE COMMON DISEASES
W. Ouwehand (NHS Blood and Transplant Cambridge Centre, Cambridge, United Kingdom)

09.45 – 10.00
4A-S21-04 LEGAL ASPECTS OF TRANSFUSION
F. Décary (HEMA Quebec, Quebec, Canada)

08.30 – 10.00 Milan

Parallel Session S22: Plasma derivatives and fractionation
 

08.30 – 08.55
4A-S22-01 QUALITY OF PLASMA AND ITS FRACTIONATION
T. Burnouf (HPPS, Lille, France)

08.55 – 09.20
4A-S22-02 RESEARCH AND DEVELOPMENT OF PLASMA-DERIVED PRODUCTS IN CHINA
J. Zhang (Academy of Military Medical Sciences, Beijing, China)

09.20 – 09.45
4A-S22-03 IVIG PRODUCTS: AN UPDATE OF THEIR MECHANISMS OF ACTION
J. Semple (St. Michael's Hospital, Toronto, Canada)

09.45 – 10.00
4A-S22-04 AN IMPROVED, CONCENTRATED, MINI-POOL SOLVENT-DETERGENT TREATED CRYOPRECIPITATE PREPARED USING A NEWLY-DEVELOPED SINGLE-USE BAG PROCESSING SYSTEM
M. El-Akiaby, T. Burnouf, C. Caron, H.A. Goubran, M. Radosevich, J. Goudemand (HPPS, Lille, France)

08.30 – 10.00 Napels

Parallel Session S23: Donor recruitment and retention in the Asian region
 

08.30 – 09.00
4A-S23-01 SOCIAL MARKETING AND EFFECTIVE COMMUNICATION STRATEGIES
C.K. Lin (Hong Kong Red Cross Blood Transfusion Service, Hong Kong, SAR China)

09.00 – 09.30
4A-S23-02 DONOR RECRUITMENT AND RETENTION IN SOUTH EAST ASIA
R. Bindusara (NBTS Central Blood Bank, Colombo, Sri Lanka)

09.30 – 09.45
4A-S23-03 COMPREHENSIVE PROMOTION STRATEGIES FACILITATE BLOOD DONOR RECRUITMENT AND RETENTION IN LOW BLOOD-DONATING SEASON
Z. Qu (Wuhan blood center, Wuhan, China)

09.45 – 10.00
4A-S23-04 DO PHLEBOTOMISTS WORK IN BLOOD DONATION?
C.K. Lee, J. Hong, J.N.S. Leung, A. Lau, C.K. Lin (Hong Kong Red Cross Blood Transfusion Service, Hong Kong, SAR China)

08.30 – 10.00 Florence

Parallel Session S24: New approaches to transfusion transmitted diseases (TTD)
 

08.30 – 09.00
4A-S24-01 US BLOOD DONOR SCREENING FOR TRYPANOSOMA CRUZI: CLINICAL STUDIES AND FIRST YEAR EXPERIENCE
S. Stramer (American Red Cross, Gaithersburg, USA)

09.00 – 09.30
4A-S24-02 ISBT WP ON TTI
S. Wendel (Hopital Sirio-Libanes, Sao Paolo, Brazil)

09.30 – 09.45
4A-S24-03 CELL LINES DERIVED FROM MURINE SPLEEN AND BONE MARROW ARE SUSCEPTIBLE TO INFECTION WITH TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE) AGENTS
L. Cervenakova, S. Akimov, O. Yakovleva, I. Vasilyeva, C. McKenzie (American Red Cross, Rockville, Maryland, USA)

09.45 – 10.00
4A-S24-04 USE OF PROTEIN CHIPS FOR BIOMARKERS DISCOVERY IN PLASMA DONATIONS
C. Fournier-Wirth, S. Molina, D. Misse, S. Roche, S. Badiou, P. Maurel, J. Coste (Etablissement Français du Sang de Pyrénées-Méditerranée, Montpellier, France)

08.30 – 10.00 Sicily

Parallel Session S25: Stem cell harvesting and plasticity
 

08.30 – 09.00
4A-S25-01 STEM AND PROGENITOR CELLS IN HAEMOPOIETIC TISSUES: POTENTIALITY AND CONTRIBUTION TO BLOOD AND TISSUE REGENERATION
T. Tonn, R. Henschler, H. Boenig, E. Seifried (RCBDS Institute of Transfusion Medicine, Frankfurt am Main, Germany)

09.00 – 09.30
4A-S25-02 STEM CELL AND REGENERATIVE MEDICINE RESEARCH IN CHINA
X.T. Pei (Academy of Military Medical Sciences, Beijing, China)

09.30 – 09.45
4A-S25-03 STEM CELL - PLATELET COMPLEXES IN STEM CELL PRODUCTS
S.E. Kraus, J.J. Zwaginga, Y. van Hensbergen (Sanquin / LUMC, Leiden, The Netherlands)

09.45 – 10.00
4A-S25-04 EFFECTS OF PLATELET RICH PLASMA ON EXPANSION AND DIFFERETIATION OF UMBILICAL CORD BLOOD CD133+ STEM CELLS TO MEGAKARYOCYTE PROGENITOR CELLS
M. Kheirandish, A. Noroozi Aghideh, H. Abolghasemi, A. Gharabaghian, S.D. Siadat, M. Aghaeii Pour, S. Hajati (Research Center of Iranian Blood Transfusion Organization, Tehran, Iran)

10.00 – 10.30 Exhibition Area

COFFEE/TEA BREAK

10.30 – 12.00 Ballroom G - L

Plenary Session 4
 

10.30 – 11.15
4B-PL04-01 NEW ENZYME FAMILIES FOR CONVERSION OF CARBOHYDRATE ANTIGENS – APPLICATIONS FOR TRANSFUSION AND TISSUE TRANSPLANTATION
M. Olsson (Lund University Hospital, Lund, Denmark)

11.15 – 12.00
4B-PL04-02 CELLULAR BLOOD BANKING AND (POTENTIAL) CELLULAR THERAPIES
H. Eichler (Institut für Klinische Hämostaseologie und Transfusionsmedizin, Homburg/Saar, Germany)

12.00 – 14.00

LUNCH BREAK AND SATELLITE SYMPOSIA

Satellite Symposium

12.15 – 13.45 Milan

Satellite Symposium organised by Octapharma

SS8: Prion reduction: still an open issue in the transfusion of plasma?

Chair: Larisa Cervenakova

Since the first cases of vCJD appeared, major concerns were raised on the possibility to transmit the disease with the infusion of plasma. Whether the concerns raised are founded or not is today still an open issue. This has lead some regulatory authorities to ask for special measures to reduce the theoretical load of prions in all biopharmaceutical plasma derived products, includeding biopharmaceutical solvent-detergent plasma for transfusion. The symposium will discuss the actual risk of prions in plasma and explain how a prion reduction step for biopharmaceutical solvent-detergent plasma can be implemented.

14.00 – 15.30 Ballroom G - L

Parallel Session S26: Non-infectious hazards of transfusion
 

14.00 – 14.20
4C-S26-01 HAZARDS DUE TO ERYTHROCYTE ALLOANTIBODIES
W. Mayr (Medical University of Vienna, Wien, Austria)

14.20 – 14.40
4C-S26-02 LEUCOCYTE ANTIBODY-MEDIATED TRANSFUSION REACTIONS
J. Bux (German Red Cross Blood Service West, Hagen, Germany)

14.40 – 15.00
4C-S26-03 TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD (TACO)
M.A. Popovsky (Haemonetics Corporation, Braintree, USA)

15.00 – 15.15
4C-S26-04 CHARACTERISTICS OF DONORS AND BLOOD PRODUCTS INVOLVED IN TRALI CASES
D. van Stein, E.A.M. Beckers, L. Porcelijn, N.M. Lardy, K. Sintnicolaas, A. Brand, D.J. van Rhenen (Sanquin Blood Bank, Rotterdam, The Netherlands)

15.15 – 15.30
4C-S26-05 PLATELET COMPONENTS ASSOCIATED WITH ACUTE TRANSFUSION REACTIONS: THE ROLE OF PLATELET-DERIVED SOLUBLE CD40-LIGAND
O. Garraud, F. Cognasse, J-M. Pryrat, I. Corash, J.C. Osselaer (EFS, Saint-Etienne, France)

14.00 – 15.30 Milan

Parallel Session S27: Basic and experimental transfusion related research
 

14.00 – 14.15
4C-S27-01 SURFACE SIALIC ACID PREVENTS SHEDDING OF GPIBA BY METALLOPROTEINASES DURING PLATELET STORAGE AND RESCUES IN VIVO SURVIVAL OF MURINE PLATELETS
A.J.G. Jansen, E.C. Josefsson, V. Rumjantseva, J.H. Hartwig, K.M. Hoffmeister (Brigham & Women's Hospital and Harvard Medical School, Boston, USA)

14.15 – 14.30
4C-S27-02 THE MINIMAL FVIII PROMOTER SEQUENCE IS SUITABLE FOR STABLE EXPRESSION IN PRIMARY HEPATOCYTES AND HEPATIC CELL LINES USING THIRD GENERATION LENTIVIRAL VECTORS
S. Heinz, V. Picanco, D. Abriss, T. Tonn, E. Seifried (Institute for Transfusion Medicine and Immunohematology, Frankfurt Am Main, Germany)

14.30 – 14.45
4C-S27-03 IMMUNE TOLERANCE INDUCED BY EXOSOMES DERIVED FROM REGULATORY DENDRITIC CELLS
H. Fan, Y. Liu, L. Zhao (Shanghai Blood Center, Shanghai, China)

14.45 – 15.00
4C-S27-04 ALLOGENEIC IVIG-PRIMED LEUKOCYTES AMELIORATE MURINE IMMUNE THROMBOCYTOPENIA: IMPLICATIONS FOR A CELL-BASED THERAPY TO REDUCE CONSUMPTION OF IVIG?
A. Lazarus, A. Crow, V. Siragam, J. Freedman (Canadian Blood Services, Toronto, Canada)

15.00 – 15.15
4C-S27-05 IGG-MEDIATED REGULATION OF THE MURINE IMMUNE RESPONSE TO TRANSFUSED RBC IS ASSOCIATED WITH A REDUCTION IN B CELL PRIMING: IMPLICATIONS FOR THE MECHANISM OF ACTION OF ANTI-D IN THE PREVENTION OF HDFN?
H. Lazarus, D. Brinc, H. Le-Tien, R. Crow, V.K. Siragam, J. Freedman (Canadian Blood Services, Toronto, Canada)

15.15 – 15.30
4C-S27-06 NOVEL MOUSE ANTI-MOUSE/HUMAN ß3 INTEGRIN MONOCLONAL ANTIBODIES: DEVELOPMENT AND CHARACTERIZATION OF NEW REAGENTS FOR RESEARCH IN TRANSFUSION MEDICINE
G. Zhu, M. Webster, K. Hung, P. Chen, M. Wang, A. Reheman, H. Yang, J. Freedman, H. Ni (St. Michael's hospital/University of Toronto, Toronto, Canada)

14.00 – 15.30 Napels

Parallel Session S27: HIV
 

14.00 – 14.30
4C-S28-01 HIV: A GLOBAL PROBLEM WITH ONGOING IMPLICATIONS FOR TRANSFUSION MEDICINE
M. Busch (Blood Systems Research Institute, San Francisco, USA)

14.30 – 14.45
4C-S28-02 OBSERVED YIELD AND PROJECTED RESIDUAL RISK USING HIV INDIVIDUAL DONATION (ID)-NAT, MINIPOOL (MP)-NAT OR HIV P24 ANTIGEN (P24 AG) SCREENING IN SOUTH AFRICA
M. Vermeulen, M.P. Busch, N. Lelie, W. Sykes, R. Swanevelder, M. Le Roux, L. Gaggia, R. Reddy (SANBS, Roodepoort, South Africa)

14.45 – 15.00
4C-S28-03 FIRST TRANSMISSION OF HIV-1 BY A CELLULAR BLOOD PRODUCT AFTER MANDATORY NAT BLOOD SCREENING IN GERMANY
M. Schmidt, K. Korn, M. Nübling, M. Chudy, G. Geusendam, H. Hennig, W. Sireis, H.F. Rabenau, H.W. Doerr, A. Berger, M.K. Hourfar, K. Gubbe, A. Karl, L. Gürtler, E. Seifried (German Red Cross, Institute Frankfurt, Frankfurt, Germany)

15.00 – 15.15
4C-S28-04 FIVE YEAR MONITORING OF HIV TRANSMISSION BY BLOOD TRANSFUSION IN SOUTH AFRICA: 2001 TO 2005
S. Moshi, S. Gulube, S. Moshi, F. Ledwaba (South African National Blood Service, Johannesburg, South Africa)

15.15 – 15.30
4C-S28-05 VARIATION IN THE PERFORMANCE OF REAGENT BATCHES OF THE ABBOTT ARCHITECT HIV AG/AB COMBO CMIA DETECTED IN AN INTERNATIONAL QUALITY CONTROL PROGRAMME
W. Dimech, T. Pham, M. Karakaltsas, E. Dax (National Serology Reference Laboratory, Australia, Fitzroy, Australia)

14.00 – 15.30 Florence

Parallel Session S27: Education in transfusion medicine
 

14.00 – 14.30
4C-S29-01 EXPERIENCES ON E-LEARNING PROJECTS
D.M. Peterson, K. Robinson, T. Verrall, B. Quested (BloodSafe, Adelaide Sa, Australia)

14.30 – 15.00
4C-S29-02 ISBT WP ON EDUCATION
F. Moftah (NBTS, MOH, Mohandesin, Giza, Egypt)

15.00 – 15.15
4C-S29-03 5-YEARS EXPERIENCE WITH THE ARAB TRANSFUSION MEDICINE COURSE (ATMC): RESULTS AND PROSPECTS
G. Gabra (ISBT ATMC coordinator, Birmingham, United Kingdom)

15.15 – 15.30
4C-S29-04 EXPERIENCE WITH THE POST GRADUATE DIPLOMA IN TRNASFUSION MEDICINE
T. Nel (Drs. Voigt and Partners Bloemfontein, South Africa)

14.00 – 15.30 Sicily

Parallel Session S30: Automation and Technologies in blood transfusion
 

14.00 – 14.30
4C-S30-01 ISBT WP ON IT
P. Bruce (Finnish Red Cross Blood Service, Helsinki, Finland)

14.30 – 15.00
4C-S30-02 THE ROLE OF COMPUTERS IN DELIVERING BLOOD SAFETY
P. Ashford (ICCBA, Cardiff, United Kingdom)

15.00 – 15.20
4C-S30-03 SCREENING FOR RED CELL ANTIBODIES WITH THE AUTOVUE AUTOMATED SYSTEM: APPARENT HIGH FALSE POSITIVITY RATE
R. Soeker, A. Bird, S. Safedien, E. Rutherford (Western Province Blood Transfusion Service, Cape Town, South Africa) 

15.20 – 15.30
DISCUSSION

15.30 – 16.00 Exhibition Area

COFFEE/TEA BREAK

16.00 – 17.30 Ballroom G - L

Parallel Session S31: Nucleic Acid Amplification Testing (NAT)
 

16.00 – 16.30
4D-S31-01 NAT: CURRENT STATUS
S. Kleinman (U. British Columbia, Victoria, USA)

16.30 - 17.00
4D-S31-02 NAT SCREENING IN JAPAN - ANALYSIS OF NAT POSITIVE DONORS
H. Yugi (Nagoya, Japan)

17.00 – 17.15
4D-S31-03 HBV DNA POSITIVE BLOOD DONORS: INVESTIGATION IN THE LIVING TOGETHER SETTING
I.P. Iudicone, P.M. Palange, A.A. Agresti, M.M. Miceli, B.S. Berardini, P.C. Paluzzi, P.M. Perret, A.C. Amedeo, M.E. Mannella, P.L. Pierelli (A.O. S. Camillo Forlanini, Rome, Italy)

17.15 – 17.30
4D-S31-04 INDIVIDUAL DONOR TESTING (IDT) USING THE PROCLEIX TIGRIS SYSTEM: TWO YEAR EXPERIENCE
A.R. Bird, R. Cable, B. Mitchell, N. Lelie (Western Province Blood Transfusion Service(WPBTS), Cape Town, South Africa)

16.00 – 17.30 Milan

Parallel Session S32: Socio-economic approaches to transfusion improvements
 

16.00 – 16.30
4D-S32-01 THE ISBT SOCIO-ECONOMIC WP'S PROGRAMME OF EXTERNAL ASSESSMENT OF BLOOD SERVICES
M. Contreras (National Blood Service, London, United Kingdom)

16.30 – 17.00
4D-S32-02 THE ECONOMICS OF BLOOD SAFETY: WHERE IS THE PENDULUM NOW?
G. Sher (Canadian Blood Services, Ottawa, Canada)

17.00 – 17.30
4D-S32-03 THE HEALTH AND FINANCIAL IMPACT IN BLOOD SAFETY (OR LACK THERE OF) IN SUB SAHARAN COUNTRIES
J. McCullough (University of Minnesota, Minneapolis, USA)

16.00 – 17.30 Napels

Parallel Session S33: Resuscitation and treatment of massive transfusion
 

16.00 – 16.30
4D-S33-01 THE MANAGEMENT OF MASSIVE TRANSFUSION IN ELECTIVE SURGERY AND TRAUMA
J.-F. Hardy (Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Canada)

16.30 – 17.00
4D-S33-02 MASSIVE TRANSFUSION FOR TRAUMA: OPPORTUNITIES AND RISKS
J.R. Hess (University of Maryland, Baltimore, USA)

17.00 – 17.15
4D-S33-03 DEVELOPMENT OF MICROVASCULAR BLEEDING IN ASSOCIATION WITH MASSIVE TRANSFUSION AND CONTRIBUTING RISK FACTORS
D. Roxby, R. Sinha, R. Seshadri (Flinders Medical Centre, Bedford Park, Australia)

17.15 – 17.30
4D-S33-04 BLOOD TRANSFUSION FOR WARTIME INJURIES: EXPERIENCE FROM NORTHERN ISRAEL, SUMMER 2006
E.J. Dann, N. Dally, J. Chezar, M. Michaelson, M. Barzelay, R. Hoffman, L. Bonstein (Rambam Healthcare Campus, Haifa, Israel)

16.00– 17.45 Ballroom G - L

Parallel Session S34: Evidence based transfusion medicine
 

16.00 – 16.30
2A-S34-01 EPIDEMIOLOGICAL EVIDENCE OF EFFICACY
E. Briët (Sanquin Blood Supply Foundation, Amsterdam, The Netherlands)

16.30 – 16.55
5A-S34-02 EVIDENCE BASED TRANSFUSION MEDICINE – A VIEW FROM ASIA PACIFIC REGION
P. Flanagan (New Zealand Blood Service, Auckland, New Zealand)

16.55 – 17.20
5A-S34-03 EVIDENCE BASED TRANSFUSION MEDICINE- AMERICAN VIEW
P. Ness (Johns Hopkins Medical Institutions, Baltimore, USA)

17.20 – 17.45
5A-S34-04 PREVALENCE AND SPECIFICITY OF RED BLOOD CELL ANTIBODIES DURING PREGNANCY; SWEDEN 1982-2002
A.E. Gryfelt, A. Ploner, S. Johansson, S. Cnattingius, M. Westgren, M. Reilly, A. Wikman (Karolinska Hospital, Stockholm, Sweden)

16.00 – 17.30 Sicily

Parallel Session S35: Meet the experts: Clinical Transfusion

J. Isbister (University of Sydney, Sydney, Australia)
E. Seifried (RCBDS Institute of Transfusion Medicine, Frankfurt Am Main, Germany)
P. Holland (University of California, Davis Medical Center, Sacramento, USA)